Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
2,501
Views
8
CrossRef citations to date
0
Altmetric
Back Matter

 RRx-001, a first-in-class small molecule inhibitor of MYC and a downregulator of CD47, is an "erythrophagoimmunotherapeutic"

Bryan Oronskya Clinical and Scientific Department, EpicentRx, Inc, La Jolla, CA, USACorrespondence[email protected]
,
Corey A. Cartera Clinical and Scientific Department, EpicentRx, Inc, La Jolla, CA, USA
,
Scott Caroena Clinical and Scientific Department, EpicentRx, Inc, La Jolla, CA, USA
,
Curtis Scribnera Clinical and Scientific Department, EpicentRx, Inc, La Jolla, CA, USA
,
Arnold Oronskyb Clinical and Scientific Department, InterWest Partners, Menlo Park, CA, USA
&
Tony R. Reida Clinical and Scientific Department, EpicentRx, Inc, La Jolla, CA, USA
Article: 1746172 | Received 04 Feb 2020, Accepted 11 Feb 2020, Published online: 03 Apr 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.